not require heme as an intermediate and, thus, is not necessarily related to erythropoiesis (4) .
James and Abbott (5) reported the presence of an elevated early peak in two patients who eventually developed acute granulocytic leukemia. One of these patients had erythroid hyperplasia of the bone marrow, and the other had erythroid aplasia. From these observations it was concluded that the major portion of the early peak could not be associated with erythropoiesis. However, this conclusion is at variance with studies in which the amount of labeled urobilin in the early peak did increase after an experimental hemorrhage or was found to be increased in disease states associated with increased rates of erythropoiesis (6) .
The present study was undertaken in an attempt to define the relationship between erythropoiesis and the early labeled peak of urobilin by studying a given individual at two different rates of red cell production. With the exception of two patients who were studied before and after an experimental hemorrhage (7, 8) , this has not been done previously. Four patients with hematologic diseases that might respond favorably to therapy were selected for study. Before and after treatment these patients were given glycine-2-14C, and the specific activity of urobilin-14C was determined.
In addition, erythrokinetic function was evaluated by using either 59Fe or glycine-2-14C as a precursor of heme. We feel that the results of these studies support the concept that in man most of the early labeled peak is associated with erythropoiesis.
Methods
Fecal urobilin isolation. For each study the patients were given intravenous injections of 100 ,uc glycine-2-1'C (SA 2.6 to 4.0 ,uc per umole) in a volume of 1 to 5 ml over a 10-second period. Stool samples were collected daily and stored at -20°C until analysis. Early in the study Watson's original method for the isolation of fecal urobilin was used in a modified form (7, 9) , but the most P. V. D. BARRETT, M. J. CLINE, AND N. I. BERLIN recent method of Watson and his co-workers (10) was used in later isolations.
The term "urobilin" is used generically in this report to include the closely related pigments urobilin IXa, d-urobilin, and l-urobilin (stercobilin), which are identical from a physiologic point of view and which all may be isolated with the above method (10) . However, in any given individual only one species of urobilin is usually present. Except for patient W.G., the specific optical rotation of the urobilin crystals of each sample was determined in chloroform,' and the values obtained were consistently within the accepted limits of purity for i (inactive)-, d-, or l-urobilin (11) . In addition, the specific activity of urobilin crystals obtained by these methods was found to be constant after crystallization from ethyl acetate. To determine the specific activity of the urobilin crystals, we plated 1 to 2 mg on a preweighed 5-cm planchet with the aid of a turntable and counted in a low background thin window 8-counter2 with an efficiency of 22% and a background of 2 cpm. All samples were counted for at least a half-hour or until a minimum of 1,000 counts had been observed.
Hemin isolation. The method of Fischer (12) Crystalline urobilin-'C or hemin-"C was counted by plating the material infinitely thin on a 5-cm diameter planchet and counting in a thin window low background counter. Planchets plated with hemin that contained both "Fe and "C were counted twice, with sufficient time between the two countings to allow at least half of the "Fe to decay. Assuming that the radioactivity due to 14C remained constant during this period, one may then calculate the radioactivity due to 14C alone. Table I .
Three of the four patients were studied during two or more phases of their illnesses. For comparison, two hematologically normal individuals, R.P. and W.G., were also studied (Figure 1 (7) and NOV 19F6I
..
-...-.. time of the first study, when the patient had profound erythroid hypoplasia, there was very little incorporation of isotopic precursors into red cells or the early peak. However, after treatment, red cell production returned, and the amount of isotopic glycine incorporated into hemin and into the urobilin-14C early peak was greater than normal. (Figure 2 ), a 57-year-old man with chronic lymphocytic leukemia, was found to have almost complete erythroid aplasia of the bone marrow at the time of the initial study (January 1963). The plasma radioiron disappearance halftime was 390 minutes, and there was virtually no incorporation of radioiron into red cells and of glycine-14C into urobilin and hemin. The specific activity of the urobilin was 22 dpm per mg, and that of the hemin was 0 dpm per mg. PIT was 0.31 and RCIT 0.005, mg per kg per day. However, after treatment with prednisone and testosterone a reticulocytosis occurred, and a second study was performed (March 1963). Plasma radioiron disappearance half-time was 57 minutes, with a maximal radioiron red cell uptake of 82%. PIT was 0.74 and RCIT 0.61, mg per kg per day. The specific activity of hemin-14C after 2 weeks was 404 dpm per mg, and the maximal specific activity of urobilin-14C was 1,291 dpm per mg, which is greatly elevated. The patient was studied again in July 1964. Plasma radioiron disappearance halftime was 131 minutes, and maximal radioiron red cell uptake was 61%o. PIT was 0.63 and RCIT 0.38, mg per kg per day. The specific activity of the hemin-14C was 196 dpm per mg, and hemin-14C red cell life-span was 86 days. The specific activity of urobilin-14C reached a maximum of 596 dpm per mg.
Patient S.S. was a 45-year-old woman with chronic lymphocytic leukemia. In the first study ( Figure 3 ) her bone marrow showed almost complete erythroid aplasia. Ferrokinetic studies showed a prolonged plasma radioiron disappearance half-time of 293 minutes, with no radioiron incorporation into circulating red cells. The maximal specific activity of urobilin-"4C was 48 dpm per mg. The second study was done shortly after the peak of reticulocytosis, when the bone marrow contained 10%o erythroid precursors, many of which showed megaloblastoid changes. A radioiron study was not performed, but the maximal F. This patient with aplastic anemia was studied on only one occasion. The maximal specific activities of the hemin-j'C and urobilin-14C were both approximately 10% of the values found in normal individuals after a similar amount of glycine-2-"C. specific activity of hemin-14C was 461 dpm per mg, which is greater than normal (20) . The specific activity of the urobilin-'4C early peak was also greater than normal, with a maximal value of 459 dpm per mg.
J.F., a patient with aplastic anemia (Figure 4 ), was found to have hypoplastic bone marrow. Glycine-'4C incorporation into hemin decreased markedly (9 dpm per mg). Maximal urobilin-'4C specific activity was very low (15 dpm per mg).
Patient L.F. had refractory anemia with erythroid hyperplasia of the bone marrow, but at autopsy a diagnosis of multiple myeloma was made. Four studies were performed on L.F., a patient with refractory anemia. At the time of the first study, there was a large transfusion requirement and an extremely high specific activity of the urobilin-G'C early peak. The second study, performed after treatment, showed that the red cell production had returned towards normal and the specific activity of the urobilin-J"C early peak was within the normal range. The third and fourth studies are shown in Figure 6. 1961), plasma radioiron disappearance half-time was normal (87 minutes), but red cell radioiron uptake was low (14%o). PIT was 1.06 and RCIT 0.15, mg per kg per day. The maximal specific activity of urobilin-14C was 1,650 dpm per mg, which is markedly elevated. A hemin-4C red cell life-span was 52 days, with a maximal specific activity of 30 dpm per mg. In November 1962 ( Figure 5 ), after treatment with testosterone, the patient's plasma radioiron uptake was 60%o.
PIT at this time was 0.72 and RCIT 0.43, mg per kg per day. Red cell life-span (DFP-5H) was 131 days. The specific activity of urobilin-14C was 125 dpm per mg, which is within the normal range, and the maximal specific activity of hemin-l4C was slightly low (70 dpm per mg) (20) . In May 1963 (Figure 6 ), when the patient's rate of erythropoiesis had decreased, plasma radioiron disappearance half-time was 154 minutes, and red cell uptake was 40%o. PIT was 0.40, and RCIT 0.18, mg per kg per day. The 51chromium red cell survival half-time was 33 days. Maximal specific activity of urobilin-14C was 343 dpm per mg, and that of hemin-14C was 110 dpm per mg. In January 1964 (Figure 6 ), when the patient had a large transfusion requirement, plasma radioiron disappearance half-time was 120 minutes, with a red cell radioiron uptake of 15%o. PIT , who had previously responded to treatment, were performed when red cell production decreased and the patient became refractory to treatment. Concomitantly, the specific activity of the urobilin-A'C early peak increased to levels greater than normal.
RCOT 0.10, mg per kg per day. Maximal specific activity of urobilin-14C was 502 dpm per mg, and that of hemin-14C was 52 dpm per mg.
Discussion
The early labeled peak was first observed by Gray and co-workers (2) and London and coworkers (1) in 1950. Both groups felt that the early peak was probably related to erythropoiesis. Subsequent studies in disease states with increased erythropoiesis and after an experimental hemorrhage indicated that the maximal specific activity was increased when the rate of erythropoiesis was increased (6). However, James and Abbott (5) reported studies performed on a patient in which an increased early labeled peak was found at a time when the bone marrow showed erythroid aplasia.
The present study was designed to determine whether the early peak in man is in fact related to erythropoiesis by measuring the incorporation of glycine-2-14C into the urobilin-14C early peak at a time when erythropoiesis was markedly reduced or absent as judged by bone marrow examination, reticulocyte count, radioiron plasma clearance and red cell uptake, and glycine-2-"4C incorporation into red cell heme. Figure  6 ) showed an increasing urobilin-14C specific activity, suggesting that the bone marrow was synthesizing red cells in adequate numbers but that there were defective cells that were catabolized either in the marrow or shortly after their release into the peripheral blood. The hemoglobin-14C contained in the defective red cells was presumably converted to urobilin-14C, and thus an increased isotope content of the early peak was observed. This combination of findings can be designated as ineffective erythropoiesis. When patients A.H., S.S., and J.F. had erythroid hypoplasia of the bone marrow, essentially no erythropoiesis, and a low early peak, one may speculate that the metabolic defect was in the synthesis of hemoglobin. However, in patient L.F. with bone marrow erythroid hyperplasia, an elevated early peak, and a normal radioiron plasma clearance, it is likely that the defect occurred at a later stage and could involve the mechanism of nuclear extrusion. Electron microscopic studies by Bessis, Breton-Gorius, and Thiery (21) suggested that 5 to 10%o of the reticulocyte cytoplasmic hemoglobin is lost at the time of nuclear extrusion, and Hammel and Bessman (22) have indicated that the nucleus itself may be the site of a significant amount of hemoglobin. It is possible that if the nuclear extrusion mechanism went awry, large amounts of labeled hemoglobin would be found. It is also possible that in the normal individual the hemoglobin contained in the perinuclear cytoplasm and in the nucleus itself could represent a major source of the early peak of labeled urobilin, a possibility that would be consistent with our studies in which changes in the amounts of labeled precursor in the early peak were associated with changes in the rate of effective erythropoiesis.
After the injection of glycine-2-14C, Yamamoto, Skanderbeg, Zipursky, and Israels (23) found two peaks of isotopic incorporation in plasma bilirubin, one occurring within the first day and the second during the fourth day. The occurrence of the second peak corresponds to the time of nuclear extrusion of the group of red cells that would contain the largest amount of an isotopic precursor (24) . Evidence that labeled bilirubin appears in dog fistula bile before labeled heme can be detected in the bone marrow has also been presented (4), suggesting that a nonheme pathway for labeled bile pigment might exist. However, it is more likely that various heme-containing enzymes with rapid turnover times, such as those in the liver, may contribute to the early labeled peak, and it may be this source that accounts for the first of the two plasma bilirubin peaks. This concept is supported by recent studies in bile-fistula dogs (25, 26) in which the early peak of bile bilirubin was separated into erythropoietic and nonerythropoietic fractions by stimulating or suppressing erythropoiesis. It was found that in the normal state one-half to twothirds of the early peak was of erythropoietic origin, and that the remainder could be accounted for by the radioactivity present as hepatic nonhemoglobin heme. The presence of a hepatic contribution to the early peak of labeled urobilin in man is suggested by studies in which an early peak ap-peared in a normal individual after the ingestion of delta-aminolevulinic acid-14C, a poor in vivo precursor of red cell heme (27) , and also by the initial studies in patients A.H. and S.S., in whom urobilin specific activity was found to be very low but never absent, whereas virtually no radioiron was incorporated into the red cells (Figures 2 and  3) . In man, however, pigment production associated with erythropoiesis certainly constitutes the bulk of the fecal urobilin early peak, as shown by the extremely low urobilin specific activity in the absence of erythropoiesis in patients A.H., S.S., and J.F.
Theoretically, once the specific activity of the urobilin is known, it should be possible to calculate the total amount of precursor in the early peak if the total urobilin excretion is also known. However, the quantitative fecal urobilinogen determination is inexact, and meaningful calculations cannot be made (6, 8) . Alternatively, the amount of labeled precursor in the early and late peaks could be compared, but this would require steady state conditions for more than 120 days and would be impossible in patients without a "late" peak, such as those with rapid rates of hemolysis or those in whom the amount of labeled precursor incorporated into circulating red cells is very small. These difficulties make it necessary for one to evaluate the early peak of labeled urobilin excretion in terms of the maximal specific activity. This is a valid concept if the precursor is given intravenously over a short period of time and if fecal samples are analyzed in 1-day blocks as was done in this study. This method of comparison requires that the area under the curve be proportional to the maximal value and that the urobilin production be constant, thus making the maximal value the principal variable reflecting the total amount of isotope in the peak. With these assumptions, the contribution to the early peak in man that is not due to erythropoiesis may be estimated as approximately 7 to 10%o (J.F.), 10 to 15%o (A.H.), and 22 to 34%o (S.S.).Y
The possibility that the differences observed in the urobilin specific activities before and after treatment could be the result of changes in the total daily excretion of bile pigment was also examined. Although fecal urobilinogen determinations were not obtained in every case, it was possible to estimate the rate of pigment excretion from the transfusion requirement and the rate of change of venous hemoglobin concentration. When we made these calculations, we found that the maximal change in total bile pigment excretion was twofold, whereas the smallest change in the preand post-therapy urobilin maximal specific activities was ninefold. Thus-despite some variation in the total pigment excretion-because of the large change in the specific activity before and after treatment, it is clear that the maximal urobilin specific activities are a presently acceptable reflection of the rate of isotope excretion.
Summary
An "early peak" of labeled fecal urobilin excretion occurs during the first few days after the intravenous administration of glycine-2-14C to man. To determine if this early peak is associated with erythropoiesis, we gave four patients with hematologic diseases and two hematologically normal patients glycine-2-14C, a precursor of bile pigment, and thereafter made determinations of the amount of radioactivity in the fecal urobilin. Three patients were studied when erythropoiesis was virtually absent, and in all three instances the specific activity of the fecal urobilin-14C was markedly reduced when compared to hematologically normal subjects. Two patients (S.S. and A.H.) were studied a second time during a period of reticulocytosis and rising hemoglobin concentration. The maximal specific activity in the urobilin-14C increased approximately tenfold in patient S.S. and 60-fold in A.H. Thus, the maximal urobilin-14C specific activity was shown to be low initially when compared with normal and to increase markedly when erythropoiesis was active. This suggests that a small early labeled peak is present in man in the absence of erythropoiesis but that the bulk of the peak is associated with red cell formation in the marrow in these patients. A fourth patient with anemia and normoblastic hyperplasia of the marrow was studied four times. In this patient the maximal urobilin-14C specific activity was shown to decrease by approximately 13-fold concomitant with return of the bone marrow toward normal and return of effective erythropoiesis. 4 were begun, and prednisone was given until May 1962.
The patient was readmitted in November 1962. No transfusions had been necessary during the preceding 5 months. The Hb was 15.2 g per 100 ml, the reticulocyte count was 0.5%, and the leukocyte count was 3,800 per mm', with 60% PMN and 28% lymphocytes. The mean cell volume was 110 j?. The bone marrow hypercellularity was less marked, few sideroblasts were seen, and the maturation of the granulocytic and erythrocytic series was normal. The testosterone therapy was stopped.
The patient was admitted again in May 1963. In the interim the Hb had fallen slowly to 12 g per 100 ml. The fecal urobilinogen was 81 mg per day, and serum protein electrophoresis revealed a total protein of 6.3, albumin of 3.6, and gamma globulin of 1.2 g per 100 ml. The bone marrow contained many sideroblasts, and there was a mild shift to the left with 27% myeloblasts. Testosterone injections were reinstituted.
Transfusions became necessary in October 1963, at the rate of 3 to 4 U per month. The patient was readmitted in January 1964. The fecal urobilinogen was 419 mg per day. Bone marrow was hypercellular, with 40% of the cells present as abnormal erythroid elements with megaloblastoid changes. Many sideroblasts were present. The total protein was 6.6 g per 100 ml, and the albumin was 3.5 g per 100 ml. Unsuccessful trials of a number of hematinic agents were given, and the patient was then begun on prednisone in addition to testosterone. After 
